NCT03650933View on ClinicalTrials.gov

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

December 28, 2018

Primary Completion Date

August 17, 2022

Study Completion Date

December 31, 2025

Conditions
Diffuse Large B-Cell Lymphoma, Unspecified Site
Interventions
BIOLOGICAL

G-CHOP

6 cycles(each cycle is 3 weeks)

BIOLOGICAL

R-CHOP

6 cycles(each cycle is 3 weeks)

Trial Locations (1)

100021

RECRUITING

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Nanjing Yoko Biomedical Co., Ltd.

INDUSTRY